Are intravitreal injections essential during the COVID-19 pandemic? Global preferred practice patterns and practical recommendations
Abstract Tertiary outpatient ophthalmology clinics are high-risk environments for COVID-19 transmission, especially retina clinics, where regular follow-up is needed for elderly patients with multiple comorbidities. Intravitreal injection therapy (IVT) for chronic macular diseases, is one of the mos...
Main Authors: | A. C. S. Tan, R. Schwartz, D. Anaya, I. Chatziralli, M. Yuan, M. V. Cicinelli, L. Faes, M. Mustapha, N. Phasukkijwatana, D. Pohlmann, R. Reynolds, A. Rosenblatt, A. Savastano, S. Touhami, K. Vaezi, C. V. Ventura, D. Vogt, J. Ambati, M. D. de Smet, A. Loewenstein, the International Retina Collaborative |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | International Journal of Retina and Vitreous |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40942-022-00380-6 |
Similar Items
-
Intravitreal Ranibizumab in the Treatment of Butterfly-Shaped Pattern Dystrophy Associated with Choroidal Neovascularization: A Case Report
by: Theodoros Empeslidis, et al.
Published: (2012-02-01) -
XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration
by: Jean-François Korobelnik, et al.
Published: (2024-01-01) -
Long-Term Outcomes following Intravitreal Ranibizumab for Choroidal Neovascularization Related to Nd:YAG Laser Macular Injury: A Case Report
by: Eleni Christodoulou, et al.
Published: (2023-02-01) -
Phacoemulsification in patients with diabetic macular edema – A real-world data of 75 eyes
by: Shikha Talwar Bassi, et al.
Published: (2024-01-01) -
Intravitreal aflibercept for the treatment of patients with diabetic macular edema in routine clinical practice in Latin America: the AQUILA study
by: Francisco J. Rodríguez, et al.
Published: (2022-08-01)